Ticker
PLXCompany Name
PROTALIX BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Current Assets | Current Liabilities | Working Capital |
---|---|---|---|
6/30/2025 | $ 65.48M | $ 24.09M | $ 41.39M |
3/31/2025 | $ 60.51M | $ 24.32M | $ 36.19M |
12/31/2024 | $ 60.08M | $ 25.62M | $ 34.46M |
9/30/2024 | $ 47.85M | $ 24.22M | $ 23.63M |
6/30/2024 | $ 77.37M | $ 57.97M | $ 19.39M |
3/31/2024 | $ 75.4M | $ 54.83M | $ 20.58M |
12/31/2023 | $ 69.93M | $ 45.53M | $ 24.4M |
9/30/2023 | $ 72.62M | $ 43.36M | $ 29.26M |
6/30/2023 | $ 73.58M | $ 23.11M | $ 50.47M |
3/31/2023 | $ 55.4M | $ 31.52M | $ 23.89M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for PROTALIX BIOTHERAPEUTICS INC is calculated as follows: AssetsC [ $ 60.33M ] - LiabilitesC [ $ 43.9M ]
(=) Working Capital [ $ 16.44M ]
Minimum
Dec 31, 2020
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 2.78K |
---|---|
min | $ -465.2M |
max | $ 607.04M |
average | $ 96.5M |
median | $ 32.21M |
std | $ 173.86M |